
African countries have so far acquired around 54.9 million COVID-19 vaccines, which may cover about 2.1 per cent of the population at the continental level, the Africa CDC said.
The World
Bank (WB) and the African Union (AU)’s COVID-19 Africa Vaccine Acquisition Task
Team (AVATT) have announced a decision to work together to deploy vaccines for
400 million Africans.
The pledge
came after the president of the World Bank, David Malpass, met with the AVATT
to discuss ways to accelerate vaccine deployment to Africa, according to a
joint statement by the UN Economic Commission for Africa (UNECA).
The AVATT had
previously secured up to 400 million doses of the Johnson & Johnson
single-shot COVID-19 vaccine with the support of the African Export-Import Bank
(Afreximbank).
The bank and
the AVATT stressed the importance that countries get sufficient doses as
quickly as possible and in an affordable way, according to the statement.
COVID-19
vaccines were critical for achieving the goal of vaccinating at least 60 per
cent of Africans, said John Nkengasong, the director of the African Centres for
Disease Control and Prevention (Africa CDC) and member of the AVATT.
Benedict
Oramah, the President of Afreximbank, said his bank, by providing a 2 billion
dollar guarantee on behalf of the AU member states, was able to help put Africa
in a negotiating position with producers in negotiating vaccine procurement.
Under the
AVATT structure, AU member states were allocated vaccines according to the size
of their populations through a pooled procurement mechanism.
Once vaccines
arrive across Africa, additional efforts would be required to support their
deployment, which included in-country distribution (logistics and storage in
line with the cold-chain requirements), securing the required systems,
capacities and capabilities for vaccination.
As of Monday
evening, the number of confirmed COVID-19 cases in Africa had reached
5,049,036, with 134,818 deaths and 4,524,651 recoveries, according to the
Africa CDC.
Some 35.9
million COVID-19 doses have been administered continent-wide, accounting for
about 65 per cent of the total supply available in Africa.
With minimal
access to COVID-19 vaccines across the continent, the latest figures show that
only around 0.6 per cent of Africa’s population have received a full vaccine
regimen.
Talktokemi
No comments:
Post a Comment